| 12.10.2022 07:00 | EVG | Clinical trial update | RNS |
| 10.10.2022 11:05 | EVG | Second Price Monitoring Extn | RNS |
| 10.10.2022 11:00 | EVG | Price Monitoring Extension | RNS |
| 10.10.2022 11:00 | EOG, EVG | AIM WINNERS & LOSERS: Europa Oil, i3 Energy slide as well disappoints | Alliance |
| 10.10.2022 09:58 | EVG | Evgen Pharma shares jump 65% as licences SFX-01 composition for autism | Alliance |
| 10.10.2022 07:00 | EVG | SFX-01 licensing deal for up to $160.5m | RNS |
| 29.09.2022 07:00 | EVG | Regulatory approval for healthy volunteer study | RNS |
| 22.07.2022 07:00 | EVG | Result of AGM | RNS |
| 14.07.2022 16:39 | ZPHR, WKP, TERN | UK shareholder meetings calendar - next 7 days | Alliance |
| 14.07.2022 12:43 | EVG | Investor Presentation | RNS |
| 06.07.2022 12:25 | EVG | Notice of AGM | RNS |
| 13.06.2022 19:22 | EVG | IN BRIEF: Evgen to work with University of Michigan on asset SFX-01 | Alliance |
| 13.06.2022 07:00 | EVG | Collaboration with University of Michigan | Reach |
| 08.06.2022 14:26 | EVG | Evgen Pharma starts trial to test breast cancer tablet; loss narrows | Alliance |
| 08.06.2022 07:00 | EVG | Full Year Results | RNS |
| 07.06.2022 07:00 | EVG | Notice of Results | RNS |
| 25.05.2022 22:02 | ARBB, BMV, MAFL | TRADING UPDATES: Tekcapital fundraise; Kromek wins US government order | Alliance |
| 25.05.2022 07:00 | EVG | Collaboration with Università Sapienza di Roma | Reach |
| 29.04.2022 14:39 | EVG | Holding(s) in Company | RNS |
| 15.03.2022 14:05 | EVG | Second Price Monitoring Extn | RNS |
| 15.03.2022 14:00 | EVG | Price Monitoring Extension | RNS |
| 07.03.2022 07:00 | EVG | Manchester Breast Centre collaboration expanded | Reach |
| 18.01.2022 07:00 | EVG | Option over new sulforaphane analogues | RNS |
| 11.01.2022 07:00 | EVG | Progress with UK and US regulators for 2022 trials | RNS |
| 30.12.2021 11:35 | EVG | Holding(s) in Company | RNS |
| 08.12.2021 14:08 | EVG | Grant of Options | RNS |
| 07.12.2021 07:00 | EVG | Half-year Report | RNS |
| 23.11.2021 07:00 | EVG | Notice of Results | RNS |
| 10.11.2021 07:00 | EVG | Publication of data on SFX-01 in glioblastoma | Reach |
| 19.10.2021 14:39 | EVG | Holding(s) in Company | RNS |
| 20.09.2021 07:00 | EVG | Publication of data in glioblastoma cells | Reach |
| 02.09.2021 14:32 | EVG | Holding(s) in Company | RNS |
| 02.09.2021 14:06 | EVG | Second Price Monitoring Extn | RNS |
| 02.09.2021 14:00 | EVG | Price Monitoring Extension | RNS |
| 02.09.2021 11:05 | EVG | Second Price Monitoring Extn | RNS |
| 02.09.2021 11:01 | EVG | Glioma Orphan Drug designation granted by FDA | RNS |
| 02.09.2021 11:00 | EVG | Price Monitoring Extension | RNS |
| 25.08.2021 16:42 | EVG | Holding(s) in Company | RNS |
| 24.08.2021 16:41 | EVG | Second Price Monitoring Extn | RNS |
| 24.08.2021 16:36 | EVG | Price Monitoring Extension | RNS |
| 09.08.2021 17:06 | EVG | Holding(s) in Company | RNS |
| 20.07.2021 11:57 | EVG | Holding(s) in Company | RNS |
| 16.07.2021 13:50 | EVG | Holding(s) in Company | RNS |
| 14.07.2021 10:23 | EVG | Holding(s) in Company | RNS |
| 13.07.2021 17:02 | EVG | Result of AGM and Business Update | RNS |
| 13.07.2021 15:55 | EVG | Holding(s) in Company | RNS |
| 13.07.2021 07:00 | EVG | Glioma Orphan Drug application submitted to US FDA | RNS |
| 09.07.2021 11:05 | EVG | Second Price Monitoring Extn | RNS |
| 09.07.2021 11:00 | EVG | Price Monitoring Extension | RNS |
| 09.07.2021 07:00 | EVG | Interim Safety and Futility Analysis - STAR trial | RNS |
| 18.06.2021 07:00 | EVG | Posting of Annual Report and Notice of AGM | RNS |
| 15.06.2021 07:00 | EVG | Final Results | RNS |
| 14.06.2021 07:00 | EVG | Progress with Glioma/Glioblastoma programme | RNS |
| 14.06.2021 07:00 | EVG | Progress on metastatic breast cancer programme | RNS |
| 26.04.2021 07:00 | EVG | Appointment of Chief Medical Officer | RNS |
| 07.04.2021 07:00 | EVG | Publication on sulforaphane in COVID-19 | Reach |
| 22.03.2021 07:00 | EVG | Appointment of Chief Business Officer | RNS |
| 15.03.2021 09:00 | EVG | Holding(s) in Company | RNS |
| 11.03.2021 07:00 | EVG | Update on Data Safety Review - STAR COVID-19 trial | RNS |
| 09.03.2021 11:35 | EVG | Holding(s) in Company | RNS |
| 08.03.2021 13:49 | EVG | Holding(s) in Company | RNS |
| 05.03.2021 16:04 | EVG | Holding(s) in Company | RNS |
| 05.03.2021 09:17 | EVG | Director dealing | RNS |
| 03.03.2021 12:10 | EVG | Result of General Meeting & Total Voting Rights | RNS |
| 03.03.2021 07:00 | EVG | Result of Open Offer | RNS |
| 26.02.2021 16:39 | EVG | Holding(s) in Company | RNS |
| 17.02.2021 09:58 | EVG | Holding(s) in Company | RNS |
| 17.02.2021 07:00 | EVG | Update on patient recruitment | RNS |
| 12.02.2021 07:00 | EVG | Posting of Circular & Notice of GM | RNS |
| 02.02.2021 15:15 | EVG | Placing and Open Offer to raise up to £11 million | RNS |
| 22.01.2021 07:00 | EVG | Preclinical data on a new therapeutic target | RNS |
| 21.01.2021 07:00 | EVG | Positive pre-clinical data for lead asset SFX-01 | RNS |
| 19.01.2021 07:00 | EVG | Patient recruitment update in STAR-COVID 19 trial | RNS |
